Cholesterol Reduction Rapidly Improves Endothelial Function After Acute Coronary Syndromes
- 29 June 1999
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 99 (25), 3227-3233
- https://doi.org/10.1161/01.cir.99.25.3227
Abstract
Background —Cholesterol lowering reduces coronary events. One mechanism could be improvement of endothelial function. In line with this hypothesis, this study investigates whether cholesterol reduction can result in rapid improvement of endothelial function after acute coronary syndromes. Methods and Results —Patients with acute myocardial infarction or unstable angina and total cholesterol levels at admission ≥5.2 mmol/L or LDL ≥3.4 mmol/L were randomized to placebo (n=30) or pravastatin 40 mg daily (n=30) for 6 weeks. Brachial ultrasound was used to measure endothelium-dependent flow-mediated dilatation (FMD) and response to endothelium-independent nitroglycerin. Changes in the levels of markers of platelet activation, coagulation factors, and plasma endothelin levels were also assessed. Total and LDL cholesterol levels were similar at admission and before randomization in both groups. With pravastatin, but not with placebo, they decreased by 23% ( P P P =0.02), representing a 42% relative increase. Responses to nitroglycerin were similar during the time course of the study in the 2 groups. Markers of platelet activity, coagulation factors, and endothelin levels were not affected by pravastatin. Conclusions —Cholesterol reduction with pravastatin initiated early after acute coronary syndromes rapidly improves endothelial function after 6 weeks of therapy.Keywords
This publication has 14 references indexed in Scilit:
- Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial InfarctionThe American Journal of Cardiology, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Task force 1. Pathogenesis of coronary disease: The biologic role of risk factorsJournal of the American College of Cardiology, 1996
- Close relation of endothelial function in the human coronary and peripheral circulationsJournal of the American College of Cardiology, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemiaAmerican Journal of Hematology, 1993
- Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patientsThe Lancet, 1993
- Plasma Endothelin-1 Levels in Stable and Unstable AnginaJMIR AI, 1993
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate interventionJournal of Internal Medicine, 1989